1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Battalion Oil Corporation received a letter from NYSE American saying it is back in compliance with the Exchange's continued listing standards. The Exchange had flagged a minimum stockholders' equity deficiency in May 2025, and the company has now met the requirement for two consecutive quarters, ahead of its November 30, 2026 compliance deadline. For shareholders, this removes the listing-standard noncompliance flag on the stock, though the filing does not describe the company's financial results.
NYSE American letter dated September 16, 2026 confirms compliance with Part 10 continued listing standards
Deficiency under Sections 1003(a)(i) and 1003(a)(ii), relating to minimum stockholders' equity, was first noticed on May 30, 2025
Compliance regained two consecutive quarters under Section 1009(f), ahead of the November 30, 2026 deadline
Company will be removed from the Exchange's list of noncompliant issuers and its compliance indicator will no longer be disseminated
Nuburu said its unaudited financial statements for the three and six months ended June 30, 2026 should no longer be relied upon because of a material error in valuing a convertible note receivable from Tekne S.p.A. The company will restate those results in an amendment to its Q2 2026 Form 10-Q, and the correction increases the value of its assets by $761,001.
Error involved using a Tekne equity value of €15.2 million ($17.4 million) instead of €25.4 million ($29.0 million) to value the note as of June 30, 2026.
Fair value of the Tekne convertible note receivable rises from €20,523,000 ($23,446,999) to €21,189,000 ($24,208,000), an increase of $761,001.
The change in fair value of convertible notes receivable for the three and six months ended June 30, 2026 increases by the same amount.
Audit Committee discussed the restatement with independent auditor WithumSmith+Brown, PC.
Bone Biologics said on September 10, 2026 that it received a Nasdaq letter because its stock closed below $1 per share for 30 consecutive business days. The company has 180 days, until March 9, 2027, to regain compliance, and it plans to seek stockholder approval for a reverse stock split at its upcoming annual meeting. The notice has no immediate effect on the stock's listing, but a failure to regain compliance could lead to delisting proceedings.
Nasdaq letter dated September 10, 2026 cites closing bid price below $1 per share for the last 30 consecutive business days
Compliance period runs 180 calendar days, until March 9, 2027
Regaining compliance requires a closing bid price of at least $1 for 10 consecutive business days
Company intends to seek stockholder approval for a reverse stock split at its upcoming annual meeting
Range Capital Acquisition Corp. received a Nasdaq notice on September 11, 2026, saying it does not meet the 400 Total Holders requirement for continued listing on the Nasdaq Global Market. Nasdaq says the notice is a deficiency notification, not an imminent delisting, and it has no current effect on the listing or trading of the company's securities.
Notice received September 11, 2026, under Nasdaq Listing Rule 5450(a)(2), which requires at least 400 Total Holders
The company has 45 calendar days to submit a plan to regain compliance
If Nasdaq accepts the plan, it may grant an extension of up to 180 calendar days from the notice date; if not, the company can appeal to a Nasdaq Hearings Panel
The company is considering actions to regain compliance, but there is no assurance it will do so
CalciMedica received a Nasdaq letter on September 15, 2026 confirming it has regained compliance with the minimum bid price rule, after its closing bid stayed at $1.00 or greater for 10 consecutive business days from August 31 to September 14, 2026. The company has no outstanding Nasdaq deficiency notices, which removes the risk of delisting over the bid price issue for shareholders.
Nasdaq notice of non-compliance dated March 16, 2026, after the bid price was below $1.00 for 30 consecutive business days
Compliance deadline was September 14, 2026, 180 calendar days after the notice
Nasdaq letter received September 15, 2026 confirmed compliance with Listing Rule 5550(a)(2)
Company reports no outstanding Nasdaq deficiency notices as of the filing date
Exicure received a Nasdaq extension on September 10, 2026, to regain compliance with the $2.5 million minimum stockholders' equity requirement, with a deadline of December 2, 2026. The company said the extension does not mean it has regained compliance, and failure to meet the deadline could lead Nasdaq to issue a delisting determination that the company could appeal.
Nasdaq notified Exicure on June 5, 2026 that it did not meet the $2.5 million minimum stockholders' equity requirement under Listing Rule 5550(b)(1).
Nasdaq granted an extension on September 10, 2026, through December 2, 2026, for the company to regain compliance.
The company must publicly demonstrate compliance on or before December 2, 2026; Nasdaq will monitor compliance through the next periodic report.
If the terms are not met, Nasdaq may issue a written delisting determination, which Exicure could appeal to a Nasdaq Hearings Panel.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.